✦ LIBER ✦

Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection

✍ Scribed by Noboru Shinkai; Yasuhiro Tanaka; Etsuro Orito; Kiyoaki Ito; Tomoyoshi Ohno; Noboru Hirashima; Izumi Hasegawa; Fuminaka Sugauchi; Ryuzo Ueda; Masashi Mizokami

Book ID: 108138280
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 245 KB
Volume: 36
Category: Article
ISSN: 1386-6346
DOI: 10.1016/j.hepres.2006.08.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of antiviral therapy with lamiv

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma

✍ Teiji Kuzuya; Yoshiaki Katano; Takashi Kumada; Hidenori Toyoda; Isao Nakano; Yos 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Interferon therapy for flare-up of hepat

Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant

✍ Takashi Someya; Yoshiyuki Suzuki; Yasuji Arase; Masahiro Kobayashi; Fumitaka Suz 📂 Article 📅 2001 🏛 Springer Japan 🌐 English ⚖ 95 KB

Combined Interferon and Lamivudine Thera

Combined Interferon and Lamivudine Therapy: Is This The Treatment of Choice for Patients With Chronic Hepatitis B Virus Infection?

✍ Norah A. Terrault 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Lamivudine therapy in patients undergoin

Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu

✍ McCaughan, Geoffrey W. ;Spencer, Jenean ;Koorey, David ;Bowden, Scott ;Bartholom 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 75 KB 👁 1 views

Recurrent hepatitis B virus (HBV) infection remains a major cause of morbidity and mortality after liver transplantation. Recently, antiviral therapy, such as lamivudine, has become available for prophylaxis against HBV reactivation posttransplantation and for the treatment of HBV recurrent disease.

Predictive factors of virological non-re

Predictive factors of virological non-response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load

✍ Norio Akuta; Fumitaka Suzuki; Hitomi Sezaki; Yoshiyuki Suzuki; Tetsuya Hosaka; T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Abstract Patients with high viral load (≥1.0 × 10^5^ IU/ml) of hepatitis C virus (HCV) genotype 1b do not achieve high sustained virological response rates to interferon (IFN)/ribavirin combination therapy. Previous studies suggested that pretreatment amino acid (aa) substitution patterns in the

Serum insulin-like growth factor I evalu

Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis : A prospective study

✍ Gherardo Mazziotti; Francesca Sorvillo; Filomena Morisco; Antonella Carbone; Mar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 3 views

## Background: Although experimental studies have demonstrated an important role of insulin-like growth factor i (igf-i) in hepatocarcinogenesis, the clinical data about igf-i in patients with hepatocellular carcinoma (hcc) are scarce and controversial. to the authors' knowledge, this is the first